Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Muscle Nerve. 2011 Apr 1;43(5):694–699. doi: 10.1002/mus.21944

Figure 4.

Figure 4

Combined RAP-031 and UDCA treatment for 30 days produced substantial increases in FPT and significant increases in WBT10. (A) Body weight, (B) FPT5, (C) FPT10, (D) WBT5, (E) WBT10, and (F) FR. Black histobars – vehicle treated, gray histobars – RAP-031 and UDCA treated. N is the number of mdx mice in each group. *, **, and *** indicates p< 0.05, p< 0.01, and p<0.001, respectively, in comparison to vehicle treated mice.